• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗补体治疗在狼疮肾炎中的作用。

The role of anticomplement therapy in lupus nephritis.

机构信息

Division of Rheumatology, NYU Grossman School of Medicine, New York, New York.

Division of Rheumatology, NYU Grossman School of Medicine, New York, New York.

出版信息

Transl Res. 2022 Jul;245:1-17. doi: 10.1016/j.trsl.2022.02.001. Epub 2022 Feb 11.

DOI:10.1016/j.trsl.2022.02.001
PMID:35158097
Abstract

The complement system plays crucial roles in homeostasis and host defense against microbes. Deficiency of early complement cascade components has been associated with increased susceptibility to systemic lupus erythematosus (SLE), whereas excessive complement consumption is a hallmark of this disease. Although enhanced classical pathway activation by immune complexes was initially thought to be the main contributor to lupus nephritis (LN) pathogenesis, an increasing body of evidence has suggested the alternative and the lectin pathways are also involved. Therapeutic agents targeting complement activation have been used in LN patients and clinical trials are ongoing. We review the mechanisms by which complement system dysregulation contributes to renal injury in SLE and summarize the latest evidence on the use of anticomplement agents to manage this condition.

摘要

补体系统在维持体内平衡和宿主防御微生物方面起着至关重要的作用。早期补体级联成分的缺乏与系统性红斑狼疮 (SLE) 的易感性增加有关,而补体的过度消耗是这种疾病的标志。尽管最初认为免疫复合物增强的经典途径激活是狼疮肾炎 (LN) 发病机制的主要原因,但越来越多的证据表明替代途径和凝集素途径也参与其中。针对补体激活的治疗药物已在 LN 患者中使用,并且正在进行临床试验。我们综述了补体系统失调导致 SLE 肾脏损伤的机制,并总结了最新的关于使用抗补体药物来治疗这种疾病的证据。

相似文献

1
The role of anticomplement therapy in lupus nephritis.抗补体治疗在狼疮肾炎中的作用。
Transl Res. 2022 Jul;245:1-17. doi: 10.1016/j.trsl.2022.02.001. Epub 2022 Feb 11.
2
Intertwined pathways of complement activation command the pathogenesis of lupus nephritis.补体激活的交织途径主导狼疮肾炎的发病机制。
Transl Res. 2022 Jul;245:18-29. doi: 10.1016/j.trsl.2022.03.005. Epub 2022 Mar 14.
3
Inhibition of terminal complement: a novel therapeutic approach for the treatment of systemic lupus erythematosus.抑制补体终末成分:一种治疗系统性红斑狼疮的新型治疗方法。
Lupus. 2004;13(5):328-34. doi: 10.1191/0961203303lu1021oa.
4
Differentiating between activation via the lectin or the classical complement pathway in patients with systemic lupus erythematosus.区分系统性红斑狼疮患者通过凝集素途径或经典补体途径的激活。
Clin Exp Immunol. 2023 Dec 11;214(1):18-25. doi: 10.1093/cei/uxad070.
5
Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.狼疮性肾炎中肾小球C4d沉积的发病机制及意义:经典途径和凝集素途径的激活
Int J Clin Exp Pathol. 2013 Sep 15;6(10):2157-67. eCollection 2013.
6
Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.血栓性微血管病伴狼疮性肾炎时的替代补体途径激活。
Clin Rheumatol. 2021 Jun;40(6):2233-2242. doi: 10.1007/s10067-020-05499-1. Epub 2020 Nov 10.
7
Revisiting the complement system in systemic lupus erythematosus.重新审视系统性红斑狼疮中的补体系统。
Expert Rev Clin Immunol. 2020 Apr;16(4):397-408. doi: 10.1080/1744666X.2020.1745063. Epub 2020 Apr 6.
8
Antibodies targeting circulating protective molecules in lupus nephritis: Interest as serological biomarkers.靶向狼疮肾炎中循环保护性分子的抗体:作为血清学生物标志物的潜力。
Autoimmun Rev. 2018 Sep;17(9):890-899. doi: 10.1016/j.autrev.2018.03.013. Epub 2018 Jul 29.
9
A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy.系统性红斑狼疮相关性血栓性微血管病中依库珠单抗作用的系统评价。
BMC Nephrol. 2020 Jun 30;21(1):245. doi: 10.1186/s12882-020-01888-5.
10
Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus.低补体和高滴度抗 Sm 抗体可预测系统性红斑狼疮患者无异常尿液分析的组织病理学证实的无症状狼疮肾炎。
Rheumatology (Oxford). 2015 Mar;54(3):405-12. doi: 10.1093/rheumatology/keu343. Epub 2014 Sep 2.

引用本文的文献

1
Small Interfering RNA (siRNA) for Cardiorenal Disease: Mechanistic Insights from Preclinical and Clinical Studies.用于心肾疾病的小干扰RNA(siRNA):来自临床前和临床研究的机制见解
J Cardiovasc Transl Res. 2025 Jun 25. doi: 10.1007/s12265-025-10649-4.
2
New Insights on Childhood Lupus Nephritis.儿童狼疮性肾炎的新见解
Int J Nephrol Renovasc Dis. 2025 Jan 13;18:1-12. doi: 10.2147/IJNRD.S405789. eCollection 2025.
3
Lupus Nephritis from Pathogenesis to New Therapies: An Update.狼疮性肾炎:从发病机制到新疗法的研究进展。
Int J Mol Sci. 2024 Aug 18;25(16):8981. doi: 10.3390/ijms25168981.
4
Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons Learned.靶向系统性红斑狼疮的干扰素信号通路:经验教训。
Drugs. 2024 Jun;84(6):625-635. doi: 10.1007/s40265-024-02043-2. Epub 2024 May 28.